News

All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details!

Astrocids esclerosi múltiple

Identified the mechanisms that cause neuronal damage in patients with MS
20/06/2022
Dr.Comabella_Neurofilaments_esclerosi_multiple

Identified a biomarker that predicts long-term impairment in sclerosis

10/06/2022
EUPearl Nash Assaig clínics

Vall d’Hebron hosted IMI-2 EU-PEARL work meeting about platforms for clinical trials
17/05/2022
NoCanTher

Clinical trial designed to treat locally advanced pancreatic cancer with nanoparticles
18/03/2022
Assaigs clínics Hepatologia

Hepatology is the Service with the highest participation in liver disease trials
22/02/2022
victor vargas response

RESPONSE, a global phase III clinical trial for primary biliary cholangitis
03/02/2022
Dia Mundial Recerca en Càncer

Vall d’Hebron, committed to cancer research
23/09/2021

The Multidisciplinary Pancreatic Cancer Committee has already carried out 686 assessments on 305 patients
05/09/2021

Subscribe to our newsletters and be a part of Campus Life

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.